Alexey Tomilov

Has grant

Project Scientist

University of California, Davis
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

Dysregulated Metabolic-Matrix Axis in MASH/HCC

Open Date: 2026-01-01

Close Date: 2030-12-31

Grant: Close

Mitochondrial-mediated Lung Injury mechanisms of QACs in vivo

Open Date: 2022-08-02

Close Date: 2025-07-31

Grant: Close

'Novel Shc Blockers as potential Alzheimer's Disease Therapeutics

Open Date: 2021-09-30

Close Date: 2024-08-31

Grant: Close

Investigations of targets, mechanisms, and optimal delivery of therapeutic ketosis for functional longevity and treatment of Alzheimer's disease

Open Date: 2019-06-15

Close Date: 2025-04-30

Grant: Close

Targeting Shc to reduce inflammation and fibrosis in the aging liver

Open Date: 2018-09-30

Close Date: 2024-06-30

Articles (7)

Year:

2026

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Fatty acids are metabolized by β‐oxidation within the “mitochondrial ketogenic pathway” (MKP) to generate β‐hydroxybutyrate (BHB), a ketone body. BHB can be generated by most cells but largely by hepatocytes following exercise, fasting, or ketogenic diet consumption. BHB has been shown to modulate systemic and brain inflammation; however, its direct effects on microglia have been little studied. We investigated the impact of BHB on Aβ oligomer (AβO)‐stimulated human iPS‐derived microglia (hiMG), a model relevant to the pathogenesis of Alzheimer's disease (AD). HiMG responded to AβO with proinflammatory activation, which was mitigated by BHB at physiological concentrations of 0.1–2 mM. AβO stimulated glycolytic transcripts, suppressed genes in the β‐oxidation pathway, and induced over‐expression of AD‐relevant p46Shc, an endogenous inhibitor of thiolase, actions that are expected to suppress MKP. AβO also triggered mitochondrial Ca 2+ increase, mitochondrial reactive oxygen species production, and activation of the mitochondrial permeability transition pore. BHB potently ameliorated all the above mitochondrial changes and rectified the MKP, resulting in reduced inflammasome activation and recovery of the phagocytotic function impaired by AβO. These results indicate that microglia MKP can be induced to modulate microglia immunometabolism, and that BHB can remedy “keto‐deficiency” resulting from MKP suppression and shift microglia away from proinflammatory mitochondrial metabolism. These effects of BHB may contribute to the beneficial effects of ketogenic diet intervention in aged mice and in human subjects with mild AD.

Year:

2023

Year:

2023

Collaborators (21)

Jan Gebauer

Akademischer Rat / Faculty member

University of Cologne

GERMANY
View details

Philipp von Hundelshausen

Ludwig-Maximilians-Universität München

GERMANY
View details

Daniel Bernstein

Professor and Associate Dean for Curriculum and Scholarship

Stanford University

UNITED STATES
View details

Serena Ammendola

Associate Professor

University of Rome Tor Vergata

ITALY
View details

Antonio A Pineda-Lucena

Scientific Director

Centro de Investigación Médica Aplicada, Universidad de Navarra

SPAIN
View details

Lee-Way Jin

Professor

University of California, Davis

UNITED STATES
View details

Insaf Ahmed Qureshi

Faculty

University of Hyderabad

View details

Gracjan Michlewski

Professor

International Institute of Molecular and Cell Biology

POLAND
View details

Marta Giorgis

Professor

Università degli Studi di Torino

ITALY
View details

Luisa Iommarini

Docenti di ruolo di IIa fascia

University of Bologna

ITALY
View details

Rama Krishna Koppisetti

Staff Scientist

Washington University Physicians

UNITED STATES
View details

JiaBei Lin

Assistant Professor

Rowan University

UNITED STATES
View details

Izumi Maezawa

Professor

University of California, Davis

UNITED STATES
View details

Paulo Matos

Investigador Principal

National Institute of Health Dr. Ricardo Jorge

PORTUGAL
View details

William Lowther

Professor

Wake Forest Baptist Medical Center

UNITED STATES
View details

Linda Malkas

Professor

City Of Hope National Medical Center

UNITED STATES
View details

Anniina Virtanen

Senior Research Fellow

University of Tampere

FINLAND
View details

Kyoungmi Kim

Professor

University of California, Davis

UNITED STATES
View details

Carrie Partch

Investigator

Howard Hughes Medical Institute

UNITED STATES
View details

Stefano Gustincich

Principal Investigator - Tenured

Istituto Italiano di Tecnologia

ITALY
View details

Aldo S. de Oliveira

Computational Medicinal Chemist

Instituto Gulbenkian de Ciência

PORTUGAL
View details